Download PDF
Exp Clin Endocrinol Diabetes 2001; 109(5): 267-272
DOI: 10.1055/s-2001-16346
Articles

© Johann Ambrosius Barth

Systemic insulin-like growth factor-I, insulin and vitamin D status in relation to age-associated bone loss in women

I. žofková, R. Bahbouh, B. Bendlová
  • Institute of Endocrinology, Prague 1, Czech Republic
Further Information

Publication History

Publication Date:
31 December 2001 (online)

Also available at
    Permissions and Reprints

Summary:

This cross-sectional study, performed on 146 healthy (n = 64) or osteoporotic but otherwise normal (n = 82) pre- (n = 38) or post-menopausal (n = 108) female subjects, analyzed the relationships between bone mineral density (BMD) (measured by dual-energy X-ray absorptiometry), parameters of bone remodelling, indices of calcium homeostasis and systemic IGF-I or insulin levels against a background of natural aging. BMD (g/cm2) at the hip correlated to serum IGF-I concentration (r = 0.207, p < 0.05), as well as to insulin levels (r = 0.241, p < 0.01), while BMD at the spine correlated only to IGF-I levels (r = 0.173, p < 0.05). After adjustment for age, body mass index, serum PTH, vitamin D status and calcitonin levels, neither IGF-I nor insulin levels could be significantly related to BMD at the spine or hip. On the other hand, 25-OH vitamin D3 was found to be an important predictor of BMD at the hip (beta = 0.1686, p = 0.0437). In conclusion, this study failed to demonstrate a predictive importance of insulin-IGF-I axis to the development of bone mass. Instead, a significant predictive value to BMD at the hip was documented for serum 25-OH vitamin D3.

Key words:

Aging - bone mass - bone remodelling - insulin-IGF-I - vitamin D

References

  • 1 Audí L, Garcia-Ramírez M, Carrascosa A. Genetic determinants of bone mass.  Horm Res. 51 105-123 1999; 
    CrossrefPubMedGoogle Scholar
  • 2 Baxter R C. Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities.  Am J Physiol. 278 E967-E976 2000; 
    PubMedGoogle Scholar
  • 3 Bell N H. Editorial: Vitamin D metabolism, aging, and bone loss.  J Clin Endocrinol Metab. 80 151 1995; 
    PubMedGoogle Scholar
  • 4 Bouillon R, Bex M, van-Herck E, Laureys J, Dooms L, Lesaffre E, Ravussin E. Influence of age, sex, and insulin on osteoblast function: Osteoblast dysfunction in diabetes mellitus.  J Clin Endocrinol Metab. 80 1194-1202 1995; 
    CrossrefPubMedGoogle Scholar
  • 5 Bouillon R, Carmeliet G, Boonen S. Aging and calcium homeostasis.  Bailliere's Clin Endocrinol Metab. 11 341-365 1997; 
    PubMedGoogle Scholar
  • 6 Boonen S, Aerssens J, Dequeker J, Nicholson P, Cheng X, Lowe G, Verbeke G, Bouillon R. Age associated decline in human femoral neck cortical and trabecular content of insulin-like growth factor I: Potential implications for age-related (type II) osteoporotic fracture occurence.  Calcif Tissue Int. 61 173-178 1997; 
    CrossrefPubMedGoogle Scholar
  • 7 Boonen S, Lesaffre E, Dequeker J, Aerssens J, Nijs J, Bouillon R. Relationship between basal IGF-I and femoral bone density in women aged over 70 years: Potential implications for the prevention of age-related bone loss.  J Am Geriatr Soc. 44 1301-1306 1996; 
    PubMedGoogle Scholar
  • 8 Boonen S, Nicholson P H, Lowet G, Cheng X B, Lesaffre E, Aerssens J, Dequeker J. Determinants of age-associated changes in os calcis ultrasonic indices in elderly women: Potential involvement of geriatric hyposomatotropinism in bone fragility.  Age-Ageing. 26 139-146 1997; 
    PubMedGoogle Scholar
  • 9 Canalis E. Insulin-like growth factors and osteoporosis.  Bone. 21 215-216 1997; 
    CrossrefPubMedGoogle Scholar
  • 10 Chihara K, Sugimoto T. The action of GH/IGF-I/IGFBP in osteoblasts.  Horm Res 48 (00(Suppl 5)) 45-49 1997; 
    PubMedGoogle Scholar
  • 11 Conover C A. IGFs and cellular aging.  Endocrine. 7 93-94 1997; 
    PubMedGoogle Scholar
  • 12 Garnero P, Somay-Rendu E, Delmas P D. Low serum IGF-1 and occurrence of osteoporotic fractures in postmenopausal women.  Lancet. 355 898-899 2000; 
    CrossrefPubMedGoogle Scholar
  • 13 Jehle P M, Jehle D R, Mohan S, Böhm B O. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in type 1 and type 2 diabetes mellitus patients.  J Endocrinol. 159 297-306 1998; 
    CrossrefPubMedGoogle Scholar
  • 14 Jones G, Dwyer T. Bone mass in prepubertal children: gender differences and the role of physical activity and sunlight exposure.  J Clin Endocrinol Metab. 83 4274-4279 1998; 
    CrossrefPubMedGoogle Scholar
  • 15 Kassem M, Brixen K, Blum W, Mosekilde L, Eriksen E F. No evidence for spontaneous or growth-hormone-stimulated serum levels of insulin-like growth factor (IGF)-I, IGF-II or IGF binding protein 3 in women with spinal osteoporosis.  Eur J Endocrinol. 131 150-155 1994; 
    PubMedGoogle Scholar
  • 16 Khaw K-T, Sneyd M-J, Compston J. Bone density, parathyroid hormone and 25-hydroxyvitamin D concentrations in middle aged women.  Br Med J. 305 273-277 1992; 
    PubMedGoogle Scholar
  • 17 Kristiansson J O, Valdimarsson O, Sigurdsson G, Franzson L, Olafsson I, Steingrimsdottir L. Serum 25-hydroxyvitamin D levels and bone mineral density in 16-20 years-old girls: Lack of association.  J Intern Med. 243 381-388 1998; 
    CrossrefPubMedGoogle Scholar
  • 18 Langlois J A, Rosen C J, Visser M, Hannan M T, Harris T, Wilson P WF, Kiel D P. Association between insulin-like growth factor I and bone mineral density in older women and men: The Framingham Heart Study.  J Clin Endocrinol Metab. 83 4257-4262 1998; 
    CrossrefPubMedGoogle Scholar
  • 19 Ljunghall S, Johansson A G, Burman P, Kämpe O, Lindh E, Karlsson F A. Low plasma levels of insulin-like growth factor 1 (IGF-1) in male patients with idiopathic osteoporosis.  J Intern Med. 232 59-64 1992; 
    PubMedGoogle Scholar
  • 20 Lloyd M E, Hart D J, Nandra D, McAlindon T E, Wheeler M, Doyle D V, Spector T D. Relation between insulin-like growth factor-I concentrations, osteoarthritis, bone density, and fractures in the general population: The Chingford study.  Ann Rheum Dis. 55 870-874 1996; 
    PubMedGoogle Scholar
  • 21 Lukert B, Higgins J, Stoskopf M. Menopausal bone loss is partially regulated by dietary intake of vitamin D.  Calcif Tissue Int. 51 173-179 1992; 
    PubMedGoogle Scholar
  • 22 Miyakoshi N, Richman C, Qin X Z, Baylink D J, Mohan S. Effects of recombinant insulin-like growth factor-binding protein-4 on bone formation parameters in mice.  Endocrinology. 140 5719-5728 1999; 
    CrossrefPubMedGoogle Scholar
  • 23 Mohan S, Baylink D J. Development of a simple valid method for the complete removal of insulin-like growth factor (IGF)-binding proteins from IGFs in human serum and other biological fluids: Comparison with acid-ethanol treatment and C18 Sep-Pak separation.  J Clin Endocrinol Metab. 80 637-647 1995; 
    CrossrefPubMedGoogle Scholar
  • 24 Ooms M E, Lips P, Roos J C, van der Vijgh W JF, Popp-Snijders C, Bezemer P D, Bouter L M. Vitamin D status and sex hormone binding globulin: Determinants of bone turnover and bone mineral density in elderly women.  J Bone Miner Res. 10 1177-1184 1995; 
    PubMedGoogle Scholar
  • 25 Perry H M, Horowitz M, Morley J E, Patrick P, Vellas B, Baumgartner R, Garry P J. Longitudinal changes in serum 25-hydroxyvitamin D in older people.  Metab Clin Exp. 48 1028-1032 1999; 
    CrossrefPubMedGoogle Scholar
  • 26 Pfeilschrifter J, Scheidt-Nave C, Leidig-Bruckner G, Woltge H W, Blum W F, Wüster C, Haack D, Ziegler R. Relationship between circulating insulin-like growth factor components and sex hormones in a population-based sample of 50- to 80-years old men and women.  J Clin Endocrinol Metab. 81 2534-2540 1996; 
    CrossrefPubMedGoogle Scholar
  • 27 Pfeilschrifter J, Ziegler R. Relationship between IGF-I and skeletal aging.  Eur J Endocrinol. 138 617-618 1998; 
    CrossrefPubMedGoogle Scholar
  • 28 Ravn P, Overgaard K, Spencer E M, Christiansen C. Insulin-like growth factors I and II in healthy women with and without established osteoporosis.  Eur J Endocrinol. 132 313-319 1995; 
    PubMedGoogle Scholar
  • 29 Reed B Y, Zerwekh J E, Sakhaee K, Breslau N A, Gottschalk F, Pak C Y. Serum IGF 1 is low and correlated with osteoblastic surface in idiopathic osteoporosis.  J Bone Miner Res. 10 1218-1224 1995; 
    PubMedGoogle Scholar
  • 30 Reid I R, Evans M C, Cooper G J, Ames R W, Stapleton J. Circulating insulin levels are related to bone density in normal postmenopausal women.  Am J Physiol. 265 E655-E659 1993; 
    PubMedGoogle Scholar
  • 31 Rosen C J, Dimai H P, Vereault D, Donahue L R, Beamer W G, Farley J, Linkhart S, Linkhart T, Mohan S, Baylink D J. Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone densities.  Bone. 21 217-223 1997; 
    CrossrefPubMedGoogle Scholar
  • 32 Rosen C J, Donahue L R. Insulin-like growth factors and bone: The osteoporosis connection revisited (43310).  Proc Soc Exp Biol Med. 219 1-7 1998; 
    PubMedGoogle Scholar
  • 33 Scharla S H, Scheidt-Nave C, Leidig G, Woitge H, Wüster C, Seibel M J, Ziegler R. Lower serum 25-hydroxyvitamin D is associated with increased bone resorption markers and lower bone density at the proximal femur in normal females: A population-based study.  Exp Clin Endocrinol Diabetes. 104 289-292 1996; 
    PubMedGoogle Scholar
  • 34 Seck T, Scheppach B, Scharla S, Diel I, Blum W F, Bismar H, Schmid G, Krempien B, Ziegler R, Pfeilschifter J. Concentration of insulin-like growth factor (IGF)-I and -II in iliac crest bone matrix from pre- and postmenopausal women: Relationship to age, menopause, bone turnover, bone volume, and circulating IGFs.  J Clin Endocrinol Metab. 83 2331-2337 1998; 
    CrossrefPubMedGoogle Scholar
  • 35 Thomas D M, Kong W N, Best J D. Insulin and bone: A clinical and scientific review.  Endocrinol Metab. 4 5-17 1997; 
    PubMedGoogle Scholar
  • 36 Zamora S A, Rizzoli R, Belli D C, Slosman D O, Bonjour J P. Vitamin D supplementation during infancy is associated with higher bone mineral mass in prepubertal girls.  J Clin Endocrinol Metab. 84 4541-4544 1999; 
    CrossrefPubMedGoogle Scholar

Ivana žofkováM.D., D.Sc. 

Institute of Endocrinology

Národni′ 8

116 94 Prague 1

Czech Republic

Phone: +420 2 2490307

Fax: +420 2 24905325

      >